Bgm (BGM) Other Non-Current Assets (2019 - 2025)
Bgm's (BGM) quarterly Other Non-Current Assets came in at $117478.0 in Q3 2025, up 156.96% on a QoQ basis from $45718.0 in Q1 2025.
Bgm (BGM) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Bgm (BGM) has 6 years of Other Non-Current Assets data on file, last reported at $117478.0 in Q3 2025.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $117478.0 in Q3 2025; TTM through Sep 2025 was $117478.0, a N/A change from a year earlier, with the FY2025 full-year figure at $117478.0, changed N/A from the prior year.
- Other Non-Current Assets for Q3 2025 stood at $117478.0, up from $45718.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for BGM reached as high as $200.9 billion in Q1 2021 and fell as low as $45718.0 in Q1 2025.
- Historically, Other Non-Current Assets has averaged $80.7 billion across 4 years, with a median of $327104.0 in 2021.
- Across the five-year window, Other Non-Current Assets soared 117.93% in 2021 and tumbled 47.14% in 2022, its largest moves.
- Year by year, Other Non-Current Assets stood at $327104.0 in 2021, then tumbled by 47.14% to $172911.0 in 2022, then soared by 101053621.28% to $174.7 billion in 2023, then slumped by 100.0% to $117478.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $117478.0 in Q3 2025, $45718.0 in Q1 2025, and $174.7 billion in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 233.20 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 169,000.00 |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 117,478.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 117,478.00 |
| Mar 31, 2025 | 45,718.00 |
| Mar 31, 2023 | 174.73 Bn |
| Sep 30, 2022 | 172,911.00 |
| Mar 31, 2022 | 189.18 Bn |
| Sep 30, 2021 | 327,104.00 |
| Mar 31, 2021 | 200.86 Bn |
| Sep 30, 2020 | 150,093.00 |
| Sep 30, 2019 | 402,057.00 |